A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder (TPIP) in Healthy Participants
Clinical trial NCT06091579 · COMPLETED
Trial details
- NCT number
- NCT06091579
- Sponsor
- Insmed Incorporated
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-17
- Primary completion
- 2021-01-12
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.